Literature DB >> 20223217

Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns.

Igal Finarov1, Nina Moor, Naama Kessler, Liron Klipcan, Mark G Safro.   

Abstract

The existence of three types of phenylalanyl-tRNA synthetase (PheRS), bacterial (alphabeta)(2), eukaryotic/archaeal cytosolic (alphabeta)(2), and mitochondrial alpha, is a prominent example of structural diversity within the aaRS family. PheRSs have considerably diverged in primary sequences, domain compositions, and subunit organizations. Loss of the anticodon-binding domain B8 in human cytosolic PheRS (hcPheRS) is indicative of variations in the tRNA(Phe) binding and recognition as compared to bacterial PheRSs. We report herein the crystal structure of hcPheRS in complex with phenylalanine at 3.3 A resolution. A novel structural module has been revealed at the N terminus of the alpha subunit. It stretches out into the solvent of approximately 80 A and is made up of three structural domains (DBDs) possessing DNA-binding fold. The dramatic reduction of aminoacylation activity for truncated N terminus variants coupled with structural data and tRNA-docking model testify that DBDs play crucial role in hcPheRS activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223217     DOI: 10.1016/j.str.2010.01.002

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  26 in total

1.  Conservation of coevolving protein interfaces bridges prokaryote-eukaryote homologies in the twilight zone.

Authors:  Juan Rodriguez-Rivas; Simone Marsili; David Juan; Alfonso Valencia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-13       Impact factor: 11.205

2.  Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease.

Authors:  Anthony Antonellis; Stephanie N Oprescu; Laurie B Griffin; Amer Heider; Andrea Amalfitano; Jeffrey W Innis
Journal:  Hum Mutat       Date:  2018-04-10       Impact factor: 4.878

Review 3.  Structural analyses clarify the complex control of mistranslation by tRNA synthetases.

Authors:  Min Guo; Paul Schimmel
Journal:  Curr Opin Struct Biol       Date:  2011-12-10       Impact factor: 6.809

4.  Idiosyncrasy and identity in the prokaryotic Phe-system: crystal structure of E. coli phenylalanyl-tRNA synthetase complexed with phenylalanine and AMP.

Authors:  Inbal Mermershtain; Igal Finarov; Liron Klipcan; Naama Kessler; Haim Rozenberg; Mark G Safro
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

5.  Cell-specific proteomic analysis in Caenorhabditis elegans.

Authors:  Kai P Yuet; Meenakshi K Doma; John T Ngo; Michael J Sweredoski; Robert L J Graham; Annie Moradian; Sonja Hess; Erin M Schuman; Paul W Sternberg; David A Tirrell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

6.  Universal pathway for posttransfer editing reactions: insights from the crystal structure of TtPheRS with puromycin.

Authors:  Dmitry Tworowski; Liron Klipcan; Moshe Peretz; Nina Moor; Mark G Safro
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

Review 7.  Architecture and metamorphosis.

Authors:  Min Guo; Xiang-Lei Yang
Journal:  Top Curr Chem       Date:  2014

8.  Chimeric human mitochondrial PheRS exhibits editing activity to discriminate nonprotein amino acids.

Authors:  Ekaterine Kartvelishvili; Moshe Peretz; Dmitry Tworowski; Nina Moor; Mark Safro
Journal:  Protein Sci       Date:  2015-12-24       Impact factor: 6.725

Review 9.  Drugging tRNA aminoacylation.

Authors:  Joanne M Ho; Erol Bakkalbasi; Dieter Söll; Corwin A Miller
Journal:  RNA Biol       Date:  2018-02-02       Impact factor: 4.652

10.  Structural Aspects of Phenylalanylation and Quality Control in Three Major Forms of Phenylalanyl-tRNA Synthetase.

Authors:  Liron Klipcan; Igal Finarov; Nina Moor; Mark G Safro
Journal:  J Amino Acids       Date:  2010-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.